Literature DB >> 20549576

Relationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis.

Fang Fang1, Jia Wang, Lei Yao, Xiao-Jia Yu, Lu Yu, Long Yu.   

Abstract

The X-ray repair complementing defective repair in Chinese hamster cells 3 (XRCC3) gene is a member of the RAD51 gene family. It encodes an important protein that functions in the homologous recombination repair of DNA double-strand break. In this study, our aim was to explore the relationship between XRCC3 T241M polymorphism and gastric cancer risk. Performing both the overall meta-analysis and subgroup meta-analysis based on ethnicity, source of controls, and cancer location with a total of 6 eligible studies (1,154 cases and 1,487 controls in all), we detected no significant gastric cancer risk variation for all genetic models in the overall analysis and in the subgroup analysis based on cancer location. What is interesting is in the subgroup analysis based on ethnicity, where significantly decreased gastric cancer risk was observed for recessive model in Asians (OR=0.69, 95% CI=0.50-0.95), while significantly increased gastric cancer risk was detected for dominant model in Caucasians (OR=1.45, 95% CI=1.01-2.08). In summary, according to the results of our meta-analysis, the XRCC3 T241M polymorphism might influence gastric cancer risk oppositely in Asians and Caucasians.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549576     DOI: 10.1007/s12032-010-9591-3

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  21 in total

1.  Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans.

Authors:  M R Shen; I M Jones; H Mohrenweiser
Journal:  Cancer Res       Date:  1998-02-15       Impact factor: 12.701

2.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

3.  The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden.

Authors:  Weimin Ye; Rajiv Kumar; Gabriela Bacova; Jesper Lagergren; Kari Hemminki; Olof Nyrén
Journal:  Carcinogenesis       Date:  2006-03-29       Impact factor: 4.944

4.  XRCC3 is required for efficient repair of chromosome breaks by homologous recombination.

Authors:  M A Brenneman; A E Weiss; J A Nickoloff; D J Chen
Journal:  Mutat Res       Date:  2000-03-20       Impact factor: 2.433

Review 5.  Gastric cancer.

Authors:  Vincenzo Catalano; Roberto Labianca; Giordano D Beretta; Gemma Gatta; Filippo de Braud; Eric Van Cutsem
Journal:  Crit Rev Oncol Hematol       Date:  2009-02-20       Impact factor: 6.312

6.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

7.  XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis.

Authors:  Konstantinos P Economopoulos; Theodoros N Sergentanis
Journal:  Breast Cancer Res Treat       Date:  2009-09-30       Impact factor: 4.872

8.  Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk.

Authors:  Jonine D Figueroa; Núria Malats; Nathaniel Rothman; Francisco X Real; Debra Silverman; Manolis Kogevinas; Stephen Chanock; Meredith Yeager; Robert Welch; Mustafa Dosemeci; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Gemma Castaño-Vinyals; Montserrat García-Closas
Journal:  Carcinogenesis       Date:  2007-06-08       Impact factor: 4.944

9.  Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer.

Authors:  Annamaria Ruzzo; Emanuele Canestrari; Paolo Maltese; Francesca Pizzagalli; Francesco Graziano; Daniele Santini; Vincenzo Catalano; Rita Ficarelli; Davide Mari; Renato Bisonni; Paolo Giordani; Lucio Giustini; Paolo Lippe; Rosarita Silva; Rodolfo Mattioli; Umberto Torresi; Luciano Latini; Mauro Magnani
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

10.  DNA repair gene polymorphisms and prostate cancer risk in South Australia--results of a pilot study.

Authors:  Varinderpal S Dhillon; Eric Yeoh; Michael Fenech
Journal:  Urol Oncol       Date:  2009-11-13       Impact factor: 3.498

View more
  8 in total

Review 1.  Association of XRCC3 gene rs861539 polymorphism with gastric cancer risk: evidence from a case-control study and a meta-analysis.

Authors:  Shidan Cheng; Liying Wang; Lei Wang; Zhengting Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.

Authors:  Jin-Guang Yao; Xiao-Ying Huang; Xi-Dai Long
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Quantitative assessment of the associations between DNA repair gene XRCC3 Thr241Met polymorphism and gastric cancer.

Authors:  Zhe Wang; Xu Chen; Bo Liu; Shide Li; Mingjun Liu; Hong Xue
Journal:  Tumour Biol       Date:  2013-10-03

4.  XRCC3 T241M polymorphism is associated risk of hepatocellular carcinoma in the Chinese.

Authors:  Chibo Liu; Haibao Wang
Journal:  Tumour Biol       Date:  2013-04-05

5.  Association between Single Nucleotide Polymorphisms in XRCC3 and Radiation-Induced Adverse Effects on Normal Tissue: A Meta-Analysis.

Authors:  Yu-Zhe Song; Fu-Jun Han; Min Liu; Cheng-Cheng Xia; Wei-Yan Shi; Li-Hua Dong
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

Review 6.  Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review.

Authors:  Lijun Jing; Li Su; Brian Z Ring
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

7.  Association Between X-Ray Cross-complementing Group 3 (XRCC3) Thr241Met Polymorphism and Risk of Thyroid Cancer: A Meta-Analysis.

Authors:  Wenying Lu; Guiqi Wu; Bo Zhang
Journal:  Med Sci Monit       Date:  2015-12-21

8.  Polymorphisms of XRCC3 and XRCC7 and Colorectal Cancer Risk in Khorasan Razavi Province, Iran.

Authors:  Jamshid Mehrzad; Mahdieh Dayyani; Mohammadreza Erfanian Khorasani
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.